Embryonic stem cells and gene targeting

Experimental Physiology

Volumn 85, Issue 6, 2000, Pages 603-613

  Ledermann, B ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; EMBRYO CELL; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GENE TECHNOLOGY; GENETIC ANALYSIS; GENETIC MANIPULATION; GENETIC RECOMBINATION; GENOME; GERM LINE; HUMAN; IN VIVO STUDY; METHODOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; REVIEW; SEQUENCE HOMOLOGY; STEM CELL;

EID: 0033671090     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-445X.2000.02105.x     Document Type: Review

References (122)

1. Site-directed point mutations in embryonic stem cells: A gene-targeting tag-and-exchange strategy
2. Production of goats by somatic cell nuclear transfer
3. Mouse models of human disease. Part II: Recent progress and future directions
4. Humanization of mouse 5-hydroxytryptamine 1B receptor gene by homologous recombination: In vitro and in vivo characterization
5. Formation of germ-line chimeras from embryo-derived teratocarcinoma cell lines
6. Modifying the mouse: Design and desire
7. Targeting the mouse genome: A compendium of knockouts
8. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues
9. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death
10. Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs
11. The origin and efficient derivation of embryonic stem cells in the mouse
12. RAG-2-deficient blastocyst complementation: An assay of gene function in lymphocyte development
13. Cloned transgenic calves produced from nonquiescent fetal fibroblasts
14. Investigation of coelectroporation as a method for introducing small mutations into embryonic stem cells
15. Deletion and replacement of the mouse adult beta-globin genes by a 'plug and socket' repeated targeting strategy
16. Efficient generation of transgenic BALB/c mice using BALB/c embryonic stem cells
17. Interpretation of phenotype in genetically engineered mice
18. Targeted mutation of the hprt gene in mouse embryonic stem cells
19. Virus infection in mice with targeted gene disruptions
20. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents
21. Establishment in culture of pluripotent cells from mouse embryos
22. Maintenance and differentiation in culture of pluripotential embryonic cell lines from pig blastocysts
23. Ligand-activated site-specific recombination in mice
24. Inbred strains of mice
25. Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus
26. Cut, paste, and save: New approaches to altering specific genes in mice
27. Embryonic stem cells and homologous recombination
28. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin
29. Gene-targeting studies of mammalian behavior: Is it the mutation of the background phenotype?
30. Inducible gene expression in the nervous system of transgenic mice
31. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
32. Transcriptional activation by tetracycline in mammalian cells
33. Transgenesis by means of blastocyst-derived embryonic stem cell lines
34. Embryonic stem cell lines from MRL mice allow genetic modification in a murine model of autoimmune disease
35. Insertional versus targeted transgenesis
36. Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells
37. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: Comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases
38. Targeted transgenesis
39. Cytotoxicity mediated by T cells ad natural killer cells is greatly impaired in perforin-deficient mice
40. Strain difference in establishment of mouse embryonic stem (ES) cell lines
41. A novel strategy for the negative selection in mouse embryonic stem cells operated with immunotoxin-mediated cell targeting
42. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice
43. Regulation of Cre recombinase activity by the synthetic steroid RU 486
44. Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells
45. + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses
46. Generation and analysis of interleukin-4 deficient mice
47. Inducible gene targeting in mice
48. Human therapeutic cloning
49. Establishment of embryonic stem cell lines
50. Establishment of a germ-line competent C57BL/6 embryonic stem cell line
51. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system
52. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria
53. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
54. Production of gene-targeted sheep by nuclear transfer from cultured somatic cells
55. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain
56. Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background
57. T cell development in mice lacking the CD3-zeta/eta gene
58. Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning
59. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes
60. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice
61. Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains
62. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells
63. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells
64. Differences between IL-4 and IL-4 receptor α-deficient mice in chronic Leishmaniasis reveal a protective role for IL-13 Receptor signalling
65. Production of homozygous mutant ES cells with a single targeting construct
66. Embryonic stem cells lacking a functional inhibitory G-protein subunit (alpha i2) produced by gene targeting of both alleles
67. Ten years of gene targeting: Targeted mouse mutants, from vector design to phenotype analysis
68. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3
69. Ecdysone-inducible gene expression in mammalian cells and transgenic mice
70. Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line
71. Derivation of pluripotent, embryonic cell lines from the pig and sheep
72. Hoxb-4 (Hox-2.6) mutant mice show homeotic transformation of a cervical vertebra and defects in the closure of the sternal rudiments
73. Regulatory elements in the introns of the human HPRT gene are necessary for its expression in embryonic stem cells
74. Cotransformation and gene targeting in mouse embryonic stem cells
75. B lymphocyte-specific, Cre-mediated mutagenesis in mice
76. A new embryonic stem cell line from DBA/1lacJ mice allows genetic modification in a murine model of human inflammation
77. Germline transmission of genes introduced into cultured pluripotential cells by retroviral vector
78. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP
79. Creating mouse mutants - A meeting review on conditional mouse genetics
80. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development
81. MyoD or Myf-5 is required for the formation of skeletal muscle
82. Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4
83. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts
84. Germ-line transmission of a c-abl mutation produced by targeted gene disruption in ES cells
85. Gene targeting using a mouse HPRT minigene/HPRT-deficient embryonic stem cell system: Inactivation of the mouse ERCC-1 gene
86. Genetic variation amoung 129 substrains and its importance for targeted mutagenesis in mice
87. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1
88. Mouse embryo stem cells: Their identification, propagation and manupulation
89. Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells
90. Insertion of DNA sequences into the human chromosomal β-globin locus by homologous recombination
91. Generalized lacZ expression with the ROSA26 Cre reporter strain
92. Detection of specific sequences among DNA fragments separated by gel electrophoresis
93. Use of double-replacement gene targeting to replace the murine alpha-lactalbumin gene with its human counterpart in embryonic stem cells and mice
94. Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo
95. Epigenesis: The missing beat in biotechnology?
96. Targeting sheep
97. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs
98. -1 proto-oncogene by homologous recombination in embryonic stem cells
99. Site-directed mutagenesis by gene targeting in mouse embryonic stem cells
100. Embryonic stem cell lines derived from human blastocysts
101. Primate embryonic stem cells
102. Testing an 'in-out' targeting procedure for making subtle genomic modifications in mouse embryonic stem cells
103. Targeting of the creatine kinase M gene in embryonic stem cells using isogenic and nonisogenic vectors
104. The magical touch: Genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin
105. Development and validation of swine embryonic stem cells
106. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells
107. Viable offspring derived from fetal and adult mammalian cells
108. Non-injection methods for the production of embryonic stem cell-embryo chimaeras
109. Simple and efficient production of embryonic stem cell-embryo chimeras by coculture
110. Multiple developmental defects in Engrailed-1 mutant mice: An early mid-hindbrain deletion and patterning defects in forelimbs and sternum
111. Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphteria toxin A-fragment gene in negative selection
112. Embryonic mesodermal defects in alpha 5 integrin-deficient mice
113. Negative feedback regulation of IgE synthesis by murine CD23
114. Inducible site-directed recombination in mouse embryonic stem cells
115. Gene targeting in the Ig kappa locus: Efficient generation of lambda chain-expressing B cells, independent of gene rearrangements in Ig kappa